1-20 of 84
Katie Robinson
Close
Sort by
News

Daratumumab Plus Lenalidomide Shows MRD, PFS Benefit in Newly Diagnosed MM After AHCT in Clinically Relevant Subgroups

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Daratumumab Plus Lenalidomide Shows MRD, PFS Benefit in Newly Diagnosed MM After AHCT in Clinically Relevant Subgroups
News

More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma

Katie Robinson
Published: 2024
Abstract
December 2024
View News titled, More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma
News

Teclistamab-Based Induction Regimens Achieve MRD Negativity in Patients With Transplant-Eligible NDMM

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Teclistamab-Based Induction Regimens Achieve MRD Negativity in Patients With Transplant-Eligible NDMM
News

Study Validates SCD Biomarker for Targeted P-Selectin Therapy Response

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Study Validates SCD Biomarker for Targeted P-Selectin Therapy Response
News

Revised Cytoreductive Start Criteria in PV Identify Thrombotic Risk Regardless of Conventional Risk Category

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Revised Cytoreductive Start Criteria in PV Identify Thrombotic Risk Regardless of Conventional Risk Category
News

Pirtobrutinib Shows Efficacy in Previously Treated Richter Transformation

Katie Robinson
Published: 2024
Abstract
Mid-November 2024
View News titled, Pirtobrutinib Shows Efficacy in Previously Treated Richter Transformation
News

Studying the Foundations of Aging in Hematologic Disease

Katie Robinson
Published: 2024
Abstract
Mid-November 2024
View News titled, Studying the Foundations of Aging in Hematologic Disease
News

Etoposide Safe to Combine With Brentuximab Vedotin, Results in High CRR in Peripheral T-Cell Lymphoma

Katie Robinson
Published: 2024
Abstract
November 2024
View News titled, Etoposide Safe to Combine With Brentuximab Vedotin, Results in High CRR in Peripheral T-Cell Lymphoma
News

Study in Southern Africa Increases Insight on Prevalence of MGUS

Katie Robinson
Published: 2024
Abstract
October 2024
View News titled, Study in Southern Africa Increases Insight on Prevalence of MGUS
News

Pediatric T-LBL But Not T-ALL Harbors TRB::NOTCH1 Fusions With Increased Relapse Risk

Katie Robinson
Published: 2024
Abstract
October 2024
View News titled, Pediatric T-LBL But Not T-ALL Harbors TRB::NOTCH1 Fusions With Increased Relapse Risk
News

Belamaf Plus Standard Care Shows Progression-Free Survival Benefit in R/R MM

Katie Robinson
Published: 2024
Abstract
September 2024
View News titled, Belamaf Plus Standard Care Shows Progression-Free Survival Benefit in R/R MM
News

Molecular Taxonomy of MDS May Help Guide Clinical Decisions, Trials

Katie Robinson
Published: 2024
Abstract
September 2024
View News titled, Molecular Taxonomy of MDS May Help Guide Clinical Decisions, Trials
News

Fully Automated Lugano Response Assessment Achieves High Accuracy in FDG-Avid Non-Hodgkin Lymphoma

Katie Robinson
Published: 2024
Abstract
September 2024
View News titled, Fully Automated Lugano Response Assessment Achieves High Accuracy in FDG-Avid Non-Hodgkin Lymphoma
News

Isa-KRd Attains Deep, Durable Responses in MM Despite Missing Phase II Goal

Katie Robinson
Published: 2024
Abstract
August 2024
View News titled, Isa-KRd Attains Deep, Durable Responses in MM Despite Missing Phase II Goal
News

Study Supports Firstline Ibrutinib in Younger Patients With Mantle Cell Lymphoma

Katie Robinson
Published: 2024
Abstract
August 2024
View News titled, Study Supports Firstline Ibrutinib in Younger Patients With Mantle Cell Lymphoma
News

Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL
News

Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL
News

Phase I Study Shows Long-Term Efficacy of GPRC5D-Directed CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Phase I Study Shows Long-Term Efficacy of GPRC5D-Directed CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
News

Asciminib More Effective, Safer Than Frontline Tyrosine Kinase Inhibitors for CML

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Asciminib More Effective, Safer Than Frontline Tyrosine Kinase Inhibitors for CML
News

Better Regulations, Improved Production Necessary to Boost Use of Generic Drugs in LMICs

Katie Robinson
Published: 2024
Abstract
July 2024
View News titled, Better Regulations, Improved Production Necessary to Boost Use of Generic Drugs in LMICs